Volunteer Assignments and Opportunities: Difference between revisions
| [unchecked revision] | [unchecked revision] |
No edit summary |
No edit summary |
||
| Line 257: | Line 257: | ||
|Complete | |Complete | ||
| | | | ||
| | |Need permission for figure? Update WHO? | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH | | Acute Myeloid Leukemia (AML) Megakaryoblastic with t(1;22)(p13.3;q13.1);RBM15-MKL1||Disease||Jennelle Hodge||JH | ||
| Line 275: | Line 275: | ||
|} | |} | ||
| | | | ||
| | |Add WHO reference | ||
|- | |- | ||
| Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg Conboy (Monash Health)||JH | | Acute Myeloid Leukemia (AML) with Biallelic Mutations of CEBPA||Disease||Paul deFazio, MSc, via Greg Conboy (Monash Health)||JH | ||
| Line 355: | Line 355: | ||
|Complete | |Complete | ||
| | | | ||
| | |Need permission for figure? | ||
|- | |- | ||
| Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley||JH | | Transient Abnormal Myelopoiesis (TAM) Associated with Down Syndrome||Disease||Linda Cooley||JH | ||